176 related articles for article (PubMed ID: 31754354)
1. Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells.
Gwynne WD; Shakeel MS; Wu J; Hallett RM; Girgis-Gabardo A; Dvorkin-Gheva A; Hassell JA
Cell Mol Biol Lett; 2019; 24():59. PubMed ID: 31754354
[TBL] [Abstract][Full Text] [Related]
2. Antagonists of the serotonin receptor 5A target human breast tumor initiating cells.
Gwynne WD; Shakeel MS; Girgis-Gabardo A; Kim KH; Ford E; Dvorkin-Gheva A; Aarts C; Isaac M; Al-Awar R; Hassell JA
BMC Cancer; 2020 Aug; 20(1):724. PubMed ID: 32758183
[TBL] [Abstract][Full Text] [Related]
3. Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.
Gwynne WD; Hallett RM; Girgis-Gabardo A; Bojovic B; Dvorkin-Gheva A; Aarts C; Dias K; Bane A; Hassell JA
Oncotarget; 2017 May; 8(19):32101-32116. PubMed ID: 28404880
[TBL] [Abstract][Full Text] [Related]
4. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
[TBL] [Abstract][Full Text] [Related]
5. Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer.
Hallett RM; Girgis-Gabardo A; Gwynne WD; Giacomelli AO; Bisson JN; Jensen JE; Dvorkin-Gheva A; Hassell JA
Oncotarget; 2016 Aug; 7(33):53137-53152. PubMed ID: 27447971
[TBL] [Abstract][Full Text] [Related]
6. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
7. NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro.
Simmons MJ; Serra R; Hermance N; Kelliher MA
Breast Cancer Res; 2012 Sep; 14(5):R126. PubMed ID: 22992387
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer.
Sun WY; Choi J; Cha YJ; Koo JS
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261141
[TBL] [Abstract][Full Text] [Related]
9. Molecular Investigation of the Antitumor Effects of Monoamine Oxidase Inhibitors in Breast Cancer Cells.
Alkhawaldeh A; Bardaweel S
Biomed Res Int; 2023; 2023():2592691. PubMed ID: 37841082
[TBL] [Abstract][Full Text] [Related]
10. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy.
Wang YC; Wang X; Yu J; Ma F; Li Z; Zhou Y; Zeng S; Ma X; Li YR; Neal A; Huang J; To A; Clarke N; Memarzadeh S; Pellegrini M; Yang L
Nat Commun; 2021 Jun; 12(1):3530. PubMed ID: 34112755
[TBL] [Abstract][Full Text] [Related]
11. Serotonin metabolism in rat mesangial cells: involvement of a serotonin transporter and monoamine oxidase A.
Pizzinat N; Girolami JP; Parini A; Pecher C; Ordener C
Kidney Int; 1999 Oct; 56(4):1391-9. PubMed ID: 10504491
[TBL] [Abstract][Full Text] [Related]
12. Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.
Ao A; Morrison BJ; Wang H; López JA; Reynolds BA; Lu J
PLoS One; 2011 Apr; 6(4):e18810. PubMed ID: 21533195
[TBL] [Abstract][Full Text] [Related]
13. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
14. Monoamine Oxidase Inhibitors Prevent Glucose-Dependent Energy Production, Proliferation and Migration of Bladder Carcinoma Cells.
Resta J; Santin Y; Roumiguié M; Riant E; Lucas A; Couderc B; Binda C; Lluel P; Parini A; Mialet-Perez J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233054
[TBL] [Abstract][Full Text] [Related]
15. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.
Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D
J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455
[TBL] [Abstract][Full Text] [Related]
16. PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma.
Li PC; Chen SY; Xiangfei D; Mao C; Wu CH; Shih JC
BMC Complement Med Ther; 2020 Aug; 20(1):252. PubMed ID: 32799864
[TBL] [Abstract][Full Text] [Related]
17. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
[TBL] [Abstract][Full Text] [Related]
18. Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
Inaba-Hasegawa K; Akao Y; Maruyama W; Naoi M
J Neural Transm (Vienna); 2012 Apr; 119(4):405-14. PubMed ID: 22065207
[TBL] [Abstract][Full Text] [Related]
19. A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
So JY; Lin JJ; Wahler J; Liby KT; Sporn MB; Suh N
PLoS One; 2014; 9(9):e107616. PubMed ID: 25229616
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer.
Bharti R; Dey G; Das AK; Mandal M
Br J Cancer; 2018 May; 118(11):1442-1452. PubMed ID: 29695771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
